Publications
Select keywords to filter the posts for matching content:
The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
StudyBONEMET
Year2024
Keywords- immunotherapy
- melanoma
Design and Rationale of MYOFLAME-19 RCT: MYOcardial protection to reduce inFLAMmatory heart disease due to COVID-19 Infection using CMR Endpoints
StudyMYOFLAME-19
Year2024
Keywords- cardiovascular
- COVID-19
real-world use of teriflunomide in Germany and changes in treatment patterns over time
StudyTAURUS-MS II
Year2024
Keywords- multiple sclerosis
InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices
StudyInspeCKD
Year2024
Keywords- CKD
DETECT IPN: Real-World Experience with Automated Detection of Incidental Pulmonary Nodules in an All-Comer Population
StudyDETECT IPN
Year2025
Keywords- lung cancer
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial
StudyImmunoCobiVem
Year2023
Keywords- melanoma
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
StudyADMEC-O
Year2023
Keywords- immunotherapy
- nivolumab
- Merkel cell carcinoma
Design and Rationale of MYOFLAME-19 RCT: MYOcardial protection to reduce inFLAMmatory heart disease due to COVID-19 Infection using CMR Endpoints
StudyMYOFLAME-19
Year2024
Keywords- cardiovascular
- COVID-19
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time
StudyTAURUS-MS II
Year2024
KeywordsInspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices
StudyinspeCKD
Year2024
Keywords- CKD